These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21881128)

  • 1. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.
    Baliraine FN; Rosenthal PJ
    J Infect Dis; 2011 Oct; 204(7):1120-4. PubMed ID: 21881128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
    Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
    PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
    Nawaz F; Nsobya SL; Kiggundu M; Joloba M; Rosenthal PJ
    J Infect Dis; 2009 Dec; 200(11):1650-7. PubMed ID: 19905933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic.
    Dokomajilar C; Nsobya SL; Greenhouse B; Rosenthal PJ; Dorsey G
    Antimicrob Agents Chemother; 2006 May; 50(5):1893-5. PubMed ID: 16641472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali.
    Mahamar A; Smit MJ; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Dicko OM; Diallo M; Maguiraga SO; Sankaré Y; Keita S; Samake S; Dembele A; Lanke K; Ter Heine R; Bradley J; Dicko Y; Traore SF; Drakeley C; Dicko A; Bousema T; Stone W
    Lancet Microbe; 2024 Jul; 5(7):633-644. PubMed ID: 38705163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
    Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
    Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.
    Humphreys GS; Merinopoulos I; Ahmed J; Whitty CJ; Mutabingwa TK; Sutherland CJ; Hallett RL
    Antimicrob Agents Chemother; 2007 Mar; 51(3):991-7. PubMed ID: 17194834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
    Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
    Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
    Dahlström S; Aubouy A; Maïga-Ascofaré O; Faucher JF; Wakpo A; Ezinmègnon S; Massougbodji A; Houzé P; Kendjo E; Deloron P; Le Bras J; Houzé S
    Antimicrob Agents Chemother; 2014; 58(1):1-10. PubMed ID: 24100489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.
    Happi CT; Gbotosho GO; Folarin OA; Sowunmi A; Hudson T; O'Neil M; Milhous W; Wirth DF; Oduola AM
    Antimicrob Agents Chemother; 2009 Mar; 53(3):888-95. PubMed ID: 19075074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
    Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG
    Malar J; 2008 Jun; 7():106. PubMed ID: 18547415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pfmdr1 mutations in imported African Plasmodium falciparum isolates.
    Dippmann AK; Bienzle U; Harms G; Mockenhaupt FP
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1148-50. PubMed ID: 18513774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
    Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
    Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
    Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.